Exploring strengths and limits of urinary D-chiro inositol phosphoglycans (IPG-P) as a screening test for preeclampsia: A systematic review and meta-analysis

•Most maternal and fetal poor outcomes related to preeclampsia occur in low-income countries.•A rapid noninvasive screening test for preeclampsia represents the first clinical priority.•Inositol phosphoglycans P- shown to identify in advance most of the women who will develop preeclampsia.•A meta-analysis revealed the potential of urinary IPG-P as a valid and inexpensive screening test for preeclampsia.